Article
RSV--a substantial slice of the airway disease burden and the way to a vaccine.
Paediatrics and international child health - 1 Nov 2012
Weigl Josef A I
Abstract excerpt
BACKGROUND: The impact of an active RSV vaccine in the future will depend on the true fraction of airway diseases attributable to RSV as the causal pathogen, since many pathogens contribute to the airway disease burden at the same time. This attributable slice of the airway disease burden can vary between populations, regions and seasons, and by the incidence of co-infections. Furthermore, potential future...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.